Redwood City, CA, United States of America

Bing Yang

USPTO Granted Patents = 16 (Patent Applications = 6)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.6

ph-index = 12

Forward Citations = 447(Granted Patents)

Company Filing History:

9 out of 67

Intarcia Therapeutics, Inc.

Years Active: 2001-2022

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11246913 - Suspension formulation comprising an insulinotropic peptide (2022-02-15),

2. 10441528 - Devices, formulations, and methods for delivery of multiple beneficial agents (2019-10-15),

3. 10363287 - Method of manufacturing an osmotic delivery device (2019-07-30),

4. 9682127 - Osmotic delivery device comprising an insulinotropic peptide and uses thereof (2017-06-20),

5. 9572889 - Devices, formulations, and methods for delivery of multiple beneficial agents (2017-02-21),

6. 8940316 - Osmotic delivery comprising an insulinotropic peptide and uses thereof (2015-01-27),

7. 8926595 - Devices, formulations, and methods for delivery of multiple beneficial agents (2015-01-06),

8. 8343140 - Devices, formulations, and methods for delivery of multiple beneficial agents (2013-01-01),

9. 8299025 - Suspension formulations of insulinotropic peptides and uses thereof (2012-10-30),

10. 8003665 - Salts and polymorphs of a potent antidiabetic compound (2011-08-23),

11. 7473433 - Pulmonary delivery of polyene antifungal agents (2009-01-06),

12. 7223761 - Salts and polymorphs of a potent antidiabetic compound (2007-05-29),

13. 6838075 - Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation (2005-01-04),

14. 6569406 - Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation (2003-05-27),

15. 6331309 - Hydrogel compositions for the controlled release administration of growth factors (2001-12-18),

Title: The Innovations of Bing Yang: Pioneering Advances in Drug Delivery

Introduction

Bing Yang, a prominent inventor based in Redwood City, CA, has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. With an impressive portfolio of 16 patents, Yang's work focuses on innovative formulations and delivery methods that enhance the efficacy of therapeutic agents.

Latest Patents

Among his latest inventions, Yang developed a suspension formulation comprising an insulinotropic peptide. This groundbreaking formulation includes a non-aqueous, single-phase vehicle that exhibits viscous fluid characteristics, effectively encapsulating peptides such as glucagon-like peptide-1 (GLP-1) or exenatide. The formulation not only contains a stabilizing component but also devices for administering the suspension, paving the way for enhanced therapeutic applications.

Additionally, Yang introduced devices, formulations, and methods for the simultaneous delivery of multiple beneficial agents. This invention encompasses osmotic delivery devices that facilitate the concurrent administration of diverse beneficial agents, improving treatment strategies for various conditions. The formulations created include combinations of soluble and suspended beneficial agents, making it a versatile solution for modern medicine.

Career Highlights

Bing Yang has held pivotal roles in several reputable companies, including Intarcia Therapeutics, Inc. and Nektar Therapeutics. His work in these organizations has been instrumental in advancing research and development in drug delivery technologies. His commitment to innovation has not only earned him patents but has also set benchmarks in the industry.

Collaborations

Throughout his career, Yang has collaborated with notable colleagues such as Thomas R. Alessi and Ryan D. Mercer. These partnerships have contributed to a rich exchange of ideas and technical expertise, further enhancing the impact of their collective work on pharmaceutical advancements.

Conclusion

Bing Yang's contributions to the field of drug delivery exemplify the power of innovation in healthcare. His patents reflect a deep understanding of complex formulation challenges and a commitment to improving patient outcomes. As Yang continues to explore new frontiers in pharmaceutical science, his work will undoubtedly influence the landscape of medical treatments and delivery systems for years to come.

This text is generated by artificial intelligence and may not be accurate.